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Abstract
Introduction and Objective. This paper provides an overview of the DUQuE (Deepening our Understanding of Quality
Improvement in Europe) project, the ﬁrst study across multiple countries of the European Union (EU) to assess relationships
between quality management and patient outcomes at EU level. The paper describes the conceptual framework and methods
applied, highlighting the novel features of this study.
Design. DUQuE was designed as a multi-level cross-sectional study with data collection at hospital, pathway, professional and
patient level in eight countries.
Setting and Participants. We aimed to collect data for the assessment of hospital-wide constructs from up to 30 randomly
selected hospitals in each country, and additional data at pathway and patient level in 12 of these 30.
Main outcome measures. A comprehensive conceptual framework was developed to account for the multiple levels that inﬂu-
ence hospital performance and patient outcomes. We assessed hospital-speciﬁc constructs (organizational culture and profes-
sional involvement), clinical pathway constructs (the organization of care processes for acute myocardial infarction, stroke, hip
fracture and deliveries), patient-speciﬁc processes and outcomes (clinical effectiveness, patient safety and patient experience) and
external constructs that could modify hospital quality (external assessment and perceived external pressure).
Results. Data was gathered from 188 hospitals in 7 participating countries. The overall participation and response rate were
between 75% and 100% for the assessed measures.
Conclusions. This is the ﬁrst study assessing relation between quality management and patient outcomes at EU level. The study
involved a large number of respondents and achieved high response rates. This work will serve to develop guidance in how to
assess quality management and makes recommendations on the best ways to improve quality in healthcare for hospital stake-
holders, payers, researchers, and policy makers throughout the EU.
†The list of authors of DUQuE Project Consortium is given in the Appendix.
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Introduction
Research on quality in health care has built a sizeable knowl-
edge base over the past three decades. Evidence on the effect-
iveness of organizational quality management and improvement
systems has emerged more recently [1–4]. This recent research
has addressed several questions. Do quality improvement activities
lead to better quality of care? Which quality improvement tools
are most effective? How can various quality tools be integrated
into a sensitive and effective quality and safety improvement
programme? What factors impact on the implementation of
quality strategies at hospital level? [5, 6].
Recent European Union (EU) projects, such as the ‘Methods
of Assessing Responses to Quality Improvement Strategies’
(MARQUIS) and the ‘European Research Network on Quality
Management in Health Care’ (ENQUAL), have attempted to
measure the effects of a variety of quality strategies in European
hospitals in order to provide information that payers could
use as they contract for the care of patients moving across
borders. This prior research has had limitations including an
incomplete conceptualization of antecedents and effects of
quality management systems, methodological weaknesses in
measurement strategies and limited use of data on patient
outcomes in the evaluation of the effectiveness of these strat-
egies [7–12].
This paper provides an overview of the conceptual frame-
work and methodology of the recently completed DUQuE
project (Deepening our Understanding of Quality Improvement
in Europe) funded by the European Commission 7th
Framework Programme. At its start, the goal of this project
was to evaluate the extent to which organizational quality im-
provement systems, organizational culture, professional in-
volvement and patient involvement in quality management are
related to the quality of hospital care, assessed in terms of clin-
ical effectiveness, patient safety and patient experience in a
large and diverse sample of European hospitals.
DUQuE had the following speciﬁc objectives:
(1) To develop and validate an index to assess the imple-
mentation of quality management systems across
European hospitals (addressed in three papers by
Wagner et al. [13–15]).
(2) To investigate associations between the maturity of quality
management systems and measures of organizational
culture, professional engagement and patient involvement
in quality management, including board involvement on
quality and its association with quality management
systems (addressed by Botje et al. [16]), the relationship
between organizational culture and structure and quality
management systems (addressed by Wagner et al. [17])
and the development and validation of the measures for
evaluation of clinical management by physicians and
nurses (addressed by Plochg et al. [18]).
(3) To investigate associations between the maturity of
quality management systems and patient level measures
(PLMs) of clinical effectiveness, patient safety and
patient experience including the relationships between
quality management systems at hospital and pathway
levels (addressed by Wagner et al. [19]), patient safety
and evidence based management (addressed by Sunol
et al. [20]), and patient involvement in quality management
(addressed by Groene et al. [21]).
(4) To identify factors inﬂuencing the uptake of quality
management activities by hospitals, including external
pressure as enforced by accreditation, certiﬁcation or
external assessment programmes (addressed by Shaw
et al. [22]) and the feasibility of using routine data to
compare hospital performance (addressed by Groene
et al. [23]).
Conceptual framework
The DUQuE study conceptual model was developed by a
range of collaborators with a diverse range of disciplinary
backgrounds and expertise. The model addresses four levels:
hospital, departmental (or pathway) level, patient’s level and
external factors inﬂuencing uptake of management decisions
(Fig. 1). We hypothesized that hospital level quality manage-
ment systems would be associated with hospital governance
and culture, the degree of professional involvement in man-
agement (and more concretely in quality management) and the
degree of patient involvement in quality management. We
further hypothesized that quality management systems in place
to manage speciﬁc clinical pathways (sometimes referred to as
‘clinical service lines’) would be associated with quality man-
agement activities at the hospital and pathway level as well as
with pathway culture, professionalism and patients’ involve-
ment in quality management. Moreover, we expected quality
management systems at both hospital and clinical pathway
levels to be associated with patients’ experience, and the safety
and clinical effectiveness of patient care for four selected con-
ditions (acute myocardial infarction (AMI), obstetrical deliver-
ies, hip fracture and stroke). These conditions were selected
because they cover an important range of types of care, there
are evidence-based standards for process of care against which
compliance could be assessed and there is demonstrated vari-
ability in both compliance with process of care measures and
outcomes of care (complications, mortality) that would allow for
analysis of associations between these measured constructs.
Finally, the conceptual model posited that factors external to
these quality management systems would also inﬂuence the
uptake of quality management activities such as perceived pres-
sure from hospital leadership (chief executive ofﬁcers and gov-
ernance boards) and external accreditation, certiﬁcation and
standards programmes that offer audit and feedback regarding
quality management and performance.
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Development of measures
For each construct in the conceptual model, published litera-
ture was searched to identify measure sets and instruments
used previously. Explicit criteria were used to assess and
select measures, including psychometric properties, level of
evidence and appropriateness in multi-national studies.
Whenever a validated measure, instrument or measure set
existed and was deemed appropriate, we requested permis-
sion to use it in the DUQuE study. Where we found no exist-
ing measures or instruments, new measures were developed.
After synthesis, 25 measure domains were deﬁned and
included in DUQuE (Table 1). Measures were originally
designed in English language and translated to local lan-
guages when necessary. Table 2 shows the number of cases
expected and ﬁnally gathered for each instrument designed
to operationalize measures according to hospital type. All of
the ﬁnal instruments used are available at the DUQuE’s
website [24].
The DUQuE project used a variety of measures to assess
patient experience including a generic patient experience in-
strument (NORPEQ), a measure of patient-perceived dis-
charge preparation (Health Care Transition Measure) and a
single-item measure for perceived involvement of care and hos-
pital recommendation in a DUQuE patient survey instrument.
In addition, clinical indicators to assess key patient processes
and outcomes were selected using a multi-step process (Fig. 2)
that included a search of peer-reviewed literature and extensive
searches of guidelines and other sources (a substantial amount
of patient safety literature appears in the so-called ‘grey litera-
ture’ and not in peer-reviewed publications).
Clinical indicators for each of the four clinical conditions
included in the study were collected, reviewed and rated based
on the level of evidence according to the Oxford Centre of
Evidence-Based Medicine [25] and their previous use in multi-
national studies. In the next step, ﬁve relevant European scien-
tiﬁc societies, ﬁve individual key experts with knowledge of the
health-care systems in Europe and the eight DUQuE ﬁeld test
coordinators, named country coordinators, took part in a multi-
stakeholder panel. Participants assessed the proposed clinical
indicators using a rating matrix. Criteria applied to select four to
six clinical indicators of process and outcome per condition
were: comparability, data availability, data quality across the eight
countries participating, relevance in the different EU health-care
settings and ability of the PLM to distinguish between hospitals.
The country coordinators offered structural and epidemiologic-
al information about treatment of each of the four clinical con-
ditions. The ﬁnal indicators were selected from among those
with the highest level of evidence and the best multi-stakeholder
panel rating results with previous use of an indicator in clinical
cross-national comparisons given special consideration.
In each condition one or two composite measures were devel-
oped that combined the selected indicators for the purpose of a
global analysis of the condition. Table 3 shows the ﬁnal DUQuE
indicator list with the source and level of evidence rating for
each. Data from clinical indicators were collected via medical
records abstraction using a standardized data collection method.
Design and fieldwork protocol
DUQuE was designed as a multi-level cross-sectional study
with data collection in eight countries. Selected countries had
Figure 1 DUQuE conceptual framework.
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Table 1 Constructs, measure domains and data collection methods used
Construct name Measure domain Measure domain deﬁnition Data collection method Administration system
External pressure Perceived external
pressure
Inﬂuence in hospital
management of external
factors (accreditation,
contracts, press…)
Questionnaire to CEO Electronically
administered
questionnaire
External assessment Whether the hospital has
undergone external
assessment (accreditation,
ISO)
Assessment at hospital
level performed by an
external visitor
Visit at hospital level
performed by an
external visitor. Both,
paper and electronically
administered audit
forms
Hospital
governance
Quality orientation of
the management
board
Including background in
quality, time allocated for
quality in the meetings, etc.
Questionnaire to CEO Electronically
administered
questionnaire
Hospital level
quality
management
systems (QMS)
Quality Management
System Index (QMSI)
Index to assess the
implementation of quality
management system at
hospital level
Questionnaire to
hospital quality
manager (QM)
Electronically
administered
questionnaire
Quality management
Compliance Index
(QMCI)
Measuring compliance with
quality management
strategies to plan, monitor
and improve the quality of
care
Assessment at hospital
level performed by an
external visitor
Both paper and
electronically
administered audit
forms
Clinical Quality
Implementation Index
(CQII)
Index measuring to what
extent efforts regarding key
clinical quality areas are
implemented across the
hospital
Assessment at hospital
level performed by an
external visitor
Both paper and
electronically
administered audit
forms
Hospital culture Organizational culture
Competing values
framework (CVF)
CVF has two dimensions:
structure of internal
processes within the
hospital and orientation of
the hospital to the outside
world
Questionnaires to Chair
of Board of Trustees,
CEO, Medical Director
and the highest ranking
Nurse
Electronically
administered
questionnaire
Social capital Measures common values
and perceived mutual trust
within the management
Board
Questionnaire to CEO Electronically
administered
questionnaire
Hospital patient safety
culture
Safety Attitude
Questionnaire (SAQ): Two
dimensions measuring
perceptions on patient
safety culture in terms of
teamwork and safety
climate
Questionnaires to
leading physicians and
nurses
Electronically
administered
questionnaire
Hospital
professional
involvement
Professional
involvement in
management
Measures leading doctors
and nurses involvement in
management,
administration and
budgeting and managing
medical and nursing
practice
Questionnaires to
leading physicians and
nurses
Electronically
administered
questionnaire
(continued )
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Table 1 Continued
Construct name Measure domain Measure domain deﬁnition Data collection method Administration system
Patient
involvement in
quality
management
Patient involvement in
quality at hospital level
This construct assesses
patients’ involvement in
setting standards, protocols
and quality improvement
projects. These constructs
used in previous research
(Groene, ENQUAL)
Questionnaire to
hospital quality
manager
Electronically
administered
questionnaire
Client council Measures existence and
functioning of client council
Questionnaire to
hospital quality
manager
Electronically
administered
questionnaire
Department
quality strategies
Specialized expertise
and responsibility
(SER)
Measures if specialized
expertise and clear
responsibilities are in place
at pathway level
Assessment at pathway
or department settings
performed by an
external visitor
Both paper and
electronically
administered audit
forms
Evidence-based
organization of
pathways (EBOP)
Measures if pathways are
organized to deliver existing
evidence base care
Assessment at pathway
or Department settings
performed by an
external visitor
Both paper and
electronically
administered audit
forms
Patient safety
strategies (PSS)
Measures if most
recommended safety
strategies are in place at
ward level
Assessment at pathway
or department settings
performed by an
external visitor
Both paper and
electronically
administered audit
forms
Clinical review (CR) Measures if clinical reviews
are performed
systematically
Assessment at pathway
or department settings
performed by an
external visitor
Both paper and
electronically
administered audit
forms
Department
pathway culture
Pathway patient safety
culture
SAQ: two dimensions
measuring perceptions on
patient safety culture in
terms of teamwork and
safety climate
Questionnaires to
physicians and nurses
at pathway level
Questionnaire
electronically
administered
Professionalism Professionalism Measures professional
attitudes towards
professionalism and
behaviour in their clinical
area
Questionnaires to
professionals at
pathway level
Questionnaire
electronically
administered
Patient
involvement in
quality
management
Patient involvement in
quality at
departmental level
This construct assesses
patient’s involvement in
setting standards, protocols
and quality improvement
projects. These constructs
used in previous research
(Groene, ENQUAL)
Questionnaire to
manager of care
pathways or head of
department
Questionnaire
electronically
administered
Patient information
strategies in
departments
Measures if information
literature, surveys and other
activities are conducted at
pathway or department level
Assessment at pathway
or department settings
performed by an
external visitor
Both paper and
electronically
administered audit
forms
Patient experience Generic patient
experience
Generic measure of patient
experience (NORPEQ)
Patient survey Paper-based
questionnaire
(continued )
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to have a sufﬁcient number of hospitals to fulﬁl sampling cri-
teria, represent varied approaches to ﬁnancing and organizing
health care, have research staff with experience in conducting
comprehensive ﬁeld tests and represent the geographical reach
of the EU. Turkey was included because of the status of its EU
candidacy at the start of the project. The countries invited to
participate in the ﬁeld test were the Czech Republic, England,
France, Germany, Poland, Portugal, Spain and Turkey.
Sampling strategy
We aimed to collect data for the assessment of hospital-wide
constructs from up to 30 randomly selected hospitals in each
of the 8 participating countries (Nh = 240 hospitals, maximum).
In each country, for 12 of these 30 hospitals we carried out com-
prehensive data collection at pathway and patient levels (nh = 96
hospitals, maximum).
General acute care hospitals (public or private, teaching or
non-teaching) with a minimum hospital size of 130 beds were
considered for inclusion into the study. In addition, for compre-
hensive data collection, hospitals were required to have a sufﬁ-
cient volume of care to ensure recruitment of 30 patients per
condition over a 4-month period (a sample frame of a minimum
of 90 patients). Specialty hospitals, hospital units within larger
hospitals, and hospitals not providing care for the four clinical
conditions of study were excluded from further consideration.
Each country coordinator provided to the Central Project
Coordination Team (CPCT) a de-identiﬁed hospital list (includ-
ing all hospitals with more than 130 beds, ownership and teach-
ing status) of each country for sampling purposes. A simple
random sample was taken to identify candidate hospitals for
comprehensive and partial data collection; this was oversampled
to anticipate withdrawal of participants. The sampling strategy
proved efﬁcient as the distribution of key characteristics such as
number of beds, ownership and teaching status did not differ
between country-level samples and national distributions.
Recruitment
After the preliminary sample of hospitals was selected, each
country coordinator formally invited the hospital chief executive
ofﬁcers (CEOs) to participate. A total of 548 hospitals were
approached of which 192 agreed to participate. The percentage
of hospitals accepting participation ranged from 6.7 to 96.8%
between countries. The main reasons of declining to participate
were related to time constraints, organizational aspects and the
complexity of the study. Data from 188 hospitals in 7 participat-
ing countries were included in the ﬁnal analysis. After signiﬁcant
efforts, hospitals in England were not included partly due to
delays in obtaining ethical approval and also extensive difﬁculty
recruiting hospitals.
Data collection
The CPCT facilitated communication and problem solving
during the ongoing ﬁeld test process. Preparation began in July
2010 and included sampling, recruitment, back and forward
translation and piloting of measures, preparation of materials
and training hospital coordinators in charge of retrieving data.
Data collection began formally in May 2011 and was completed
by February 2012. Several coordination actions enabled timely
data collection of professional questionnaires, patients’ surveys,
charts review, external visits and administrative data (Fig. 3).
An information technology platform was created to support
central collection of responses to professional questionnaires
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Table 1 Continued
Construct name Measure domain Measure domain deﬁnition Data collection method Administration system
Perceived patient
involvement
Measures perceived
involvement of care (from
Commonwealth Fund
sicker patients survey)
Patient survey Paper-based
questionnaire
Hospital
recommendation
Measure of hospital
recommendation (from
HCAHPS)
Patient survey Paper-based
questionnaire
Perceived continuity
of care
Measures patient-perceived
discharge preparation
(Health Care Transition
Measure)
Patient survey Paper-based
questionnaire
Perceived patients
safety
Perceived patients
safety
Measures patients’
perception of possible harm
and its management
Patient survey Paper-based
questionnaire
Clinical
effectiveness
Clinical effectiveness
indicators for AMI,
stroke, hip fracture
and deliveries
A set of clinical process
composite indicators based
on their high evidence of
impacting patients’
outcomes
Patient clinical charts
Administrative hospital
data
Electronic data
collection sheet
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and data from site visits. Among a subset of 88 hospitals a com-
prehensive data collection required them to provide administra-
tive data and administer 371 questionnaires including patients,
professionals, chart reviews and an external visit (Table 2). The
remaining hospitals provided administrative data and adminis-
tered professional questionnaires to 25 respondents. The overall
response rate for the different questionnaires was between 75
and 100% for the assessed measures (Table 2).
Once ﬁeld period was completed, all data collected was cross-
checked by the CPCT to ensure that hospital and respondents’
codes matched per country. Data were also checked for any dis-
crepancies, speciﬁcally the chart review ﬁles. All data sets were
merged and transferred to the data analysis team.
Ethical and confidentiality
DUQuE fulﬁlled the requirements for research projects as
described in the 7th framework of EU DG Research [26].
Data collection in each country complied with conﬁdentiality
requirements according to national legislation or standards of
practice of that country.
Discussion
The DUQuE project has achieved several important advances
that are detailed in the papers included in this supplement.
First, it is the ﬁrst large-scale quantitative study exploring
across a broad and diverse sample of European hospitals
several features of the implementation of hospital quality man-
agement systems and their impact on quality and safety. It
represents a major advance over previous research by includ-
ing patient-level processes and outcomes, enabling study of
the impact of current quality improvement strategies on
patient care and outcomes. Secondly, it made use of a compre-
hensive conceptual model describing the functioning of hos-
pital quality management systems and supporting a deliberate
empirical, quantitative measurement and analytic approach.
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Table 2 Data collection and response rates in the DUQuE project
Type of
questionnaire
Expected n
questionnaires per
hospital with
partial data
collection
Expected n
questionnaires per
hospital with
comprehensive data
collection
Total
questionnaires
expected
Total
questionnaires
obtained
Average
response
rate
Response
rate
country
rangea
Professional
questionnaires:
10 759 9857 90 78–98
A. Chair of the
Board of Trustees
1 1
B. Chief
executive ofﬁcer
1 1
C. Chief medical
ofﬁcer
1 1
D. Quality
manager
1 1
E. Leading
physicians and
nurses
20 20
F. Manager of
care pathways or
head of department
0 4
G. Professionals
at pathway level
0 80
M. Highest
ranking nurse in the
hospital
1 1
Patient
questionnaires
0 120 8670 6750 75 52–90
Chart reviews 0 140 10 115 9082 89 66–100
External visits 0 1 74 74 100 100–100
Administrative
routine data
1 1 188 177 94 77–100
Total amount 26 371 29 806 25 940 87%
aBy country, % response rate range (minimum–maximum).
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Thirdly, it succeeded in collecting and linking large amounts of
data from hospitals in seven countries including professional
surveys (management and baseline), patient surveys, clinical
indicators from medical records and administrative data from
participating hospitals. Fourthly, the DUQuE coordination
structure and protocol including periodic follow-up and feed-
back to hospital coordinators enabled the project to obtain the
active participation of hospitals and high response rates.
Finally, the project led to the development of new measures,
reported in this supplement, which can be used in future
research.
Despite these many achievements, the study has limitations
that are worth highlighting. First, the study was not designed
or powered to report on the results for each country. We
pooled data across countries and addressed heterogeneity in
country-level estimates in our statistical modelling using an ap-
proach that allowed country-level baselines and effects to vary.
Further covariate adjustment included hospital size, ownership
and teaching status. A second limitation is that we used a
cross-sectional study design. This was considered most appro-
priate for hypothesis testing in this project because it requires a
relatively shorter time commitment and fewer resources to
conduct, although ultimately does not allow strong conclu-
sions about causality [27]. The use of directed-acyclic graphs
guided the development of our statistical models, incorporat-
ing theory and knowledge derived from previous research
ﬁndings and this approach helps somewhat in strengthening
causal inferences from the project results. A third limitation is
related to the sampling strategy. Although a random sampling
strategy was used, a generalization to participating countries
and hospitals is limited because hospitals volunteered to par-
ticipate in the project introducing potential self-selection bias.
However, our analysis shows substantial variations in the im-
plementation of quality criteria, and outcomes, suggesting that
the effect of self-selection may be less problematic. A ﬁnal
limitation is the existence of systematic biases due to self-
report and to country differences in data coding. The study
relied on self-reported data that may introduce social desirabil-
ity bias. In many instances, we were able to use other data
sources to verify responses, but not for all measures.
Measuring clinical practice using clinical record review may
introduce systemic biases related to medical record complete-
ness practice variations among countries, but some of this is
handled through statistical adjustment for the effects of
country, hospital size, ownership and teaching status. In con-
clusion, while the design is prone to a number of limitations
we anticipated potential problems and addressed them in
study design and our analytical strategy.
This supplement presents the ﬁrst set of results from the
DUQuE project. It includes quality management indexes con-
ceptualization and development, validation of new measures
and results of tests of associations between some of the main
constructs. Future publications are intended to address re-
maining questions and secondary analyses of this very large
database. For example, papers addressing the associations
between quality management systems and key patient pro-
cesses and outcomes are planned. In addition to the research
publications, the DUQuE project website offers a set of
recommendations presented in an appraisal scheme derived
from the broader perspective of this investigation and sum-
marized for hospital managers buyers and policy makers who
may ﬁnd it useful as they redesign organization-wide
approaches to hospital care to achieve the highest levels of
quality and safety [24].
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Figure 2 Development process of DUQuE clinical indicators.
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Table 3 Clinical indicators and composite measures selected for the DUQuE project
Condition Main clinical indicators used Sourcea Level of
evidence
Acute myocardial
infarction (AMI)
Fibrinolytic agent administered within 75 min of hospital arrival AHRQ A
Primary percutaneous coronary intervention within 90 min AHRQ A/B
Thrombolytic therapy or primary percutaneous coronary
intervention given
See 1a and 2a See 1a and
2ª
Therapy given on timeb
Anti-platelet drug prescribed at discharge (ASPRIN) AHRQ A
Beta blocker prescribed at discharge AHRQ A
Medication with statin prescribed at discharge AHRQ A
ACE inhibitors prescribed at discharge AHRQ A
Appropriate medications: all four of anti-platelet, beta blocker,
statin, ACE inhibitor) prescribed at dischargeb
Deliveries Epidural anaesthesia applied within 1 h after being ordered for
vaginal births
The Danish
Clinical Registries
D
Exclusive breastfeeding at discharge WHO D
Blood transfusion during intended or realized vaginal birth The Danish
Clinical Registries
B
Acute Caesarean section
Obstetric trauma (with instrumentation) OECD B
Obstetric trauma (without instrumentation) OECD B
Mother complication: unplanned C-section, blood transfusion,
laceration and instrumentationb
The Danish
Clinical Registries
B
Adverse birth outcome (child)b The Danish
Clinical Registries
B
Birth with complicationsb The Danish
Clinical Registries
B
Hip fracture Prophylactic antibiotic treatment given within 1 h prior to surgical
incision
RAND A
Prophylactic thromboembolic treatment received on the same day
as admission (within 24 h or on same date when (one or more)
times not provided)
RAND A
Early mobilization (within 24 h or before next day when (one or
more) times not provided)
The Danish
Clinical Registries
B
In-hospital surgical waiting time <48 h [or 1 day when (one or
more] times not provided)
OECD C
Percentage of recommended care per case: indicators prophylactic
antibiotic treatment within 1 h, prophylactic thromboembolic
treatment within 24 h, early mobilization within 24 h, in-hospital
surgical waiting time <48 h = YES)b
Stroke Admitted to a specialized stroke unit within 1 day after admission The Danish
Clinical Registries
A
Platelet inhibitor treatment within 2 days after admission The Danish
Clinical Registries
A
Diagnostic examination within ﬁrst 24 h/same day after admission
using CTor MRI scan
The Danish
Clinical Registries
D
Mobilized within 48 h (or 2 days when times are missing) after
admission?
The Danish
Clinical Registries
C/D
Appropriate stroke management. All three applied: Platelet
inhibitor treatment within 2 days after admission, Diagnostic
examination (CTor MRI) within ﬁrst 24 h and Mobilized within
48 hb
aAccording the Oxford Centre of Evidence-Based Medicine.
bComposite measures (aggregation of indicators).
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Co. KG, Germany (all four conditions), Dr V. Kazandjian,
Centre for Performance Sciences (all four conditions),
Dr A. Bourek, University Center for Healthcare Quality,
Czech Republic (Delivery). In addition, in France a team
reviewed the indicators on myocardial infarction and stroke.
This review combined the Haute Autorité de la Santé (HAS)
methodological expertise on health assessment and the HAS
neuro cardiovascular platform scientiﬁc and clinical practice
expertise. We would like to thank the following reviewers from
the HAS team: L. Banaei-Bouchareb, Pilot Programme-
Clinical Impact department, HAS, N. Danchin, SFC, French
cardiology scientiﬁc society, Past President, J.M. Davy, SFC,
French cardiology scientiﬁc society, A. Dellinger, SFC,
French cardiology scientiﬁc society, A. Desplanques-Leperre,
Head of Pilot Programme-Clinical Impact department, HAS,
J.L. Ducassé, CFMU, French Emergency Medicine-learned
and scientiﬁc society, practices assessment, President,
M. Erbault, Pilot Programme-Clinical Impact department,
HAS, Y. L’Hermitte, Emergency doctor, HAS technical
advisor, B. Nemitz, SFMU, French Emergency Medicine sci-
entiﬁc society, B. Nemitz, SFMU, French Emergency
Medicine scientiﬁc society, F. Schiele, SFC, French cardiology
scientiﬁc society, C. Ziccarelli, CNPC French cardiology
learned society, M. Zuber, SFNV, Neurovascular Medicine
scientiﬁc and learned society, President. We also invited the
following ﬁve specialist organization to review the indicators:
European Midwifes Association, European Board and College
of Obstetrics and Gynaecology, European Stroke Organisation,
European Orthopaedic Research Society, European Society of
Cardiology. We thank the experts of the project for their valu-
able advices, country coordinators for enabling the ﬁeld test and
data collection, providing feedback on importance, metrics and
feasibility of the proposed indicators, hospital coordinators to
facilitate all data and the respondents for their effort and time to
ﬁll out the questionnaires.
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